Discovery Laboratories, Inc. (NASDAQ:DSCO)

CAPS Rating: 3 out of 5

A biotechnology company, which develops its proprietary surfactant technology as Surfactant Replacement Therapies for respiratory disorders and diseases.

Recs

0
Player Avatar StockTraderG (78.87) Submitted: 1/31/2012 9:44:23 PM : Outperform Start Price: $2.24 DSCO Score: +18.13

Spec Play with March 6th PDUFA date. 4th times the charm? Or is it 5 now? 6?

Featured Broker Partners


Advertisement